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Abstract
Background: Heat shock protein 27 (Hsp27), a member of the small heat shock protein family, is an apoptosis 
regulator. Our previous proteomic study showed that Hsp27 mainly expressed in human oocyte, and that Hsp27 
expression was downregulated in the ovaries derived from women with the polycystic ovary syndrome (PCOS), a well 
known endocrinal disorder with abnormal apoptotic activity and folliculogenesis. However, the exact effects of Hsp27 
downregulation on oocyte development have not yet been clarified.
Methods: The expression of Hsp27 gene was downregulated in the mouse oocytes cultured in vitro using siRNA 
adenovirus infection, while the activity of Hsp27 was decreased by microinjection of polyclonal Hsp27 antibody into 
the cytoplasm of germinal vesicle (GV) oocytes. Oocyte maturation rate was evaluated by morphological observation. 
Early stage of apoptosis was determined using Annexin-V staining analysis and some critical apoptotic factors and 
cytokines were also monitored at both mRNA level by real time RT-PCR and protein expression level by 
immunofluorescence and western blot.
Results: Hsp27 expressed at high level in maturing oocytes. Infection with AdshHsp27, and microinjection of Hsp27 
antibody into GV oocytes, resulted in the improved oocyte development and maturation. Germinal vesicle breakdown 
(GVBD) rates were significantly increased in two AdshHsp27-treated groups (88.7%, 86.0%) and Hsp27 antibody-
injected group (77.0%) when compared with control (76.2% in AdGFP, 64.4% in IgG-injected), respectively. In addition, 
the rates of metaphase II (MII) development in two AdshHsp27-treated groups (73.8%, 76.4%) and Hsp27 antibody-
injected group (67.3%) were higher than that in the controls (59.6% in AdGFP, 55.1% in IgG-injected). We also found 
that the rates of early stage of apoptosis in Hsp27 downregulated groups (46.5% and 45.6%) were higher than that in 
control group (34.1%) after 8 h of IVM. Similarly, downregulation of Hsp27 caused a significantly enhanced the 
expression of apoptotic factors (caspase 8, caspase 3) and cytokines (bmp 15 and gdf 9).
Conclusions: Downregulation of Hsp27 improved the maturation of mouse oocytes, while increased early stage of 
apoptosis in oocytes by inducing the activation of extrinsic, caspase 8-mediated pathway.
Background
Polycystic ovarian syndrome (PCOS) is known as one of
the most common endocrine disorders affecting approxi-
mately 5%-10% of women of reproductive age, and is
characterized by chronic anovulation, hyperandrogenism
and polycystic change in ovaries [1-4]. Accumulation of
small antral follicles arrested in their development, with
some atretic features, has been shown in ovaries sub-
jected to PCOS [5-9]. Those atretic follicles were closely
related to inside oocyte competence [10-12]. In addition,
oocyte developmental competence was susceptible to
derangement in PCOS, indicating that abnormal oocyte
competence in PCOS was inextricably linked to abnormal
follicular development [13-17].
In the ovary, apoptosis has been implicated in the gran-
ulose cells of atretic antral follicles and in regressing cor-
pora lutea [18-22]. Derangement of apoptotic activity was
observed in PCOS ovary tissue with the altered expres-
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sion of apoptotic-related regulators, including heat shock
proteins (Hsp 90, Hsp 10), nuclear receptor subfamily,
dickkopf homologue 3, and so on [23-26]. Hsp27, belong-
ing to the small heat shock protein family, is a molecular
chaperone protein involved in cellular protection in
response to a variety of stresses such as heat shock, toxi-
cants, injury, and oxidative stress [27-30]. Emerging evi-
dences show that Hsp27 has strong anti-apoptotic
properties by interacting directly with the caspase activa-
tion components in apoptotic pathways, consequently
exerting protective effects in apoptosis-related injuries
[31-34]. Interestingly, our previous proteomic study
showed that Hsp27, a strong anti-apoptotic regulator,
mainly localized in human oocyte, and was downregu-
lated in the ovaries derived from women with PCOS [35].
However, the alteration of apoptotic activity, as well as
effect of Hsp27, in PCOS ovaries needs to be further clar-
ified.
Our hypothesis was that Hsp27 and its related path-
w a y s  c o u l d  h a v e  s o m e  e f f e c t s  o n  oocyt e  d ev e l o p m e n t,
maturation, apoptosis and cell cycle in vivo and in vitro,
and even participate in the follicle development and
PCOS pathophysiology. In this pilot study, we firstly
investigated the effect of Hsp27 downregulation on the
meiotic progression and apoptosis in mouse oocyte
model cultured in vitro.
Methods
Animals
The ICR mice were fed ad libitum with a standard diet
and maintained in a temperature and light-controlled
room (20-22°C, 12/12 h light/dark), in accordance with
the Animal Research Committee Guidelines of Nanjing
Medical University.
Collection and culture of mouse oocytes
Germinal vesicle (GV) oocytes were collected from 6-
week-old female ICR mice. 46-48 h previously, mice were
received an intraperitoneal injection of 10 IU of pregnant
mare serum gonadotropin (PMSG, Folligon, Intervet,
Castle Hill, Australia). Mice were sacrificed, and ovaries
w e r e  p l a c e d  i n  M 2  m e d i u m  ( S i g m a ,  S t .  L o u i s ,  M O ) .
Cumulus oocyte complexes were recovered from ovaries
by repeatedly puncturing the surface with fine steel nee-
dles, and cumulus cells were removed by hyaluronidase
treatment (Sigma, 300 U/ml in PBS) under a dissecting
microscope [36]. For preparation of zona pellucida-free
oocytes, the oocytes were then exposed to acidic Tyrode's
solution (pH 2.5-3.0) with aspiration of the oocyte in and
out of a glass micropipette to remove the zona pellucida
[37]. Usually the zona pellucida was only partially dis-
solved and it could be removed by the pipette within 30s.
Ding et al reported that zona-free oocytes didn't affect
normal fertilization and blastocyst development [38].
After being immediately transferred to M2 and washed
three times, 20-25 zona-free oocytes per group were put
into 32 μl droplets of maturation medium of M16 (Sigma)
containing 10% fetal bovine serum (FBS; Invitrogen,
Grand island, NY) in a 5% humidified atmosphere at 37°C
under a layer of mineral oil. These prepared zona-free
oocytes were then used in either control or treatment
groups for further investigation.
Recombinant adenovirus generation and infection
The complementary DNA sequence of Hsp27 was
obtained from GenBank (accession no. NM_013560). The
potential target sequences for RNA interference (RNAi)
were scanned with the siRNA Target Finder and Design
Tool available from the Ambion Website [39]. The





GGAAA-3'(sense), corresponded to region 541-559 bp
and 736-754 bp after the Hsp27 start codon, respectively.
The negative control (randomized sequence) was: 5'-
GATCCCCCATGG CTAATCCGTTCTGCTTCAAGA-
GAGCAGAACGGATTAGCCATGTTTTTGGAAA-3'
[40,41]. These sequences were subcloned into pShuttle-
H1 according to the method used by Shen et al [42]. The
pShuttle-H1-siRNA/Hsp27 was then recombined with
backbone pAdEasy-1 in BJ5183 bacteria. Adenovirus
generation, amplification and titer examinations were
performed according to the simplified system described
by He et al. [43]. Viral titer was determined by plaque
assay in 293 cells.
Zona-free oocytes were incubated with adenovirus at
the same multiplicity of infection (MOI) in medium at
37°C for specific durations as indicated in the following
experiments.
Microinjection of Hsp27 antibody into GV oocytes
Hsp27 antibody (stock solution, 200 ug/ml, goat poly-
clonal, Santa Cruz Biotechnology, Santa Cruz, CA) was
microinjected into the cytoplasm of GV zona-intact
denuded oocytes as described by Dai et al [44]. Goat nor-
mal IgG-injected (Santa Cruz, CA) oocyte and untreated
oocytes were used as controls to assess injection itself
damage. To determine maturation rate in vitro, the
microinjected GV oocytes were cultured in M16 medium
(Sigma) in a 5% CO2 incubator at 37°C for 14 h. Oocytes
without GVs were scored as germinal vesicle breakdown
(GVBD) stage, while those with a polar body scored as
metaphase II (MII). The microinjection experiments
were done 10-12 replicates, using a total of > 300 oocytes.
A Nikon Diaphot ECLIPSE TE 300 inverting microscope
(Nikon UK Ltd, Kingston upon Thames, Surrey, UK)Liu et al. Reproductive Biology and Endocrinology 2010, 8:47
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equipped with Narishige MM0-202N hydraulic three-
dimensional micromanipulators (Narishige Inc., Sea Cliff,
NY) was used. Microinjection was completed in 40 min,
with volume of about 5-7 pl per oocyte.
Annexin-V staining in oocytes
Staining was performed with an Annexin-V kit according
to the manufacturer's instructions (KenGentec, Nanjing,
China). Annexin-V, a phospholipid-binding protein,
detects the translocation of phospholipid phosphatidyl-
serine (PS) from the inner to the outer cytoplasmic mem-
brane, which is known to occur during the early stages of
apoptosis. At the same time, samples were also stained
with propidium iodide (PI) to distinguish live cells from
dead cells. Briefly, zona pellucida-free oocytes infected
with siRNA adenovirus via co-culturing for 1.5 h and 8 h
were washed twice in PBS and stained with 500 μl of
binding buffer, which contained 5 μl Annexin-V-fluores-
cein isothiocyanate (FITC) and 5 μl PI for 5-15 min in the
dark. Following this, samples were mounted on sili-
conized slides and observed under a laser confocal scan-
ning microscope (ZEISS Fluorescent Microsystems,
Göttingen, Germany).
Real time RT-PCR analysis
To determine mRNA abundance, real-time RT-PCR anal-
ysis was performed using ABI 7300 (Applied Biosystems,
Foster City, CA). RNA isolation was accomplished using
the RNeasy Micro Kit (Qiagen, Valencia, CA) from the
pooled oocytes (20-25 oocytes/tube). In vitro reverse
transcription was carried out using Sensiscript Reverse
Transcription Kit (Qiagen) with oligo-dT primer at 37°C
for 60 minutes. For the real time RT-PCR reaction,
cDNAs were used as templates for amplification to quan-
tify the steady-state mRNA levels of the tested genes
using Quanti Tect SYBR Green PCR Kits (Takara Shuzo
Co Ltd, Kyoto, Japan). Relative quantitation of target gene
expression was evaluated by the 2(-Delta Delta Ct)
method [45], and the experiment was repeated at least
three times using different sets of oocytes. In our study,
beta-actin and GAPDH gene were used as the internal
standards referred to similar papers [46,47]. To ensure
only target gene sequence-specific, non-genomic prod-
ucts were amplified by real-time RT-PCR, careful design
and validation of each primer pair. Primers used for real
time RT-PCR are shown in Table 1.
Immunofluorescence
Oocytes of different treatment groups were fixed in 4%
paraformaldehyde in PBS (pH7.4) for at least 30 min at
room temperature and then incubated in permeabiliza-
tion buffer (0.5% Triton X-100 in 20 mM Hepes 3 mM
MgCl2, 50 mM NaCl, 300 mM sucrose, and 0.02% NaN3)
Table 1: Primer sequences used for quantitative real-time PCR reactions.
Primer name Genbank accession number Primer sequence Location Product size (bp)
Hsp27 NM_013560 F: 5'-GCCGCACCAGCCTTCAGC-3' 357-374 147
R: 5'-CACGCCTTCCTTGGTCTTCACT-3' 482-503
Caspase 3 NM_009810 F: 5'-ATGGGAGCAAGTCAGTGGAC-3' 128-147 137
R: 5'-CGTACCAGAGCGAGATGACA-3' 245-264
Caspase 8 NM_001080126 F: 5'-TGAAGGACAGAAAAGGAACAGA-3' 996-1017 191
R: 5'-CTTGTCACCGTGGGATAGGATA-3' 1165-1186
Caspase 9 NM_015733 F: 5'-GGCGGAGCTCATGATGTCTGTG-3' 757-778 269
R: 5'-TTCCGGTGTGCCATCTCCATCA-3' 1004-1025
Cytochrome c XR_034017 F: 5'-GGAGGCAAGCATAAGACTGG-3' 219-239 214
R: 5'-GTCTGCCCTTTCTCCCTTCT-3' 413-432
Bmp15 NM_009757 F: 5'-CTGACGACCCTACATTGCCCT-3' 467-487 232
R: 5'-TGTACATGCCAGGAACCTCTGG-3' 677-698
Gdf9 NM_008110 F: 5'-TCCCAAACCCAGCAGAAGTC-3' 426-445 195
R:5'-GGAGGAGGAAGAGGCAGAGTTG-3' 609-620
GAPDH NM_008084 F: 5'-AGGTTGTCTCCTGCGACTTCA-3' 843-903 216
R: 5'-GGGTGGTCCAGGGTTTCTTACT-3' 1048-1068
beta-actin NM_007393 F:5'-GAGACCTTCAACACCCCAGC-3' 452-471 263
R:5'-ATGTCACGCACGATTTCCC-3' 696-714
F, forward; R, reverseLiu et al. Reproductive Biology and Endocrinology 2010, 8:47
http://www.rbej.com/content/8/1/47
Page 4 of 12
for 30 min at 37°C, followed by blocking in 1% BSA for 1
h at room temperature. They were then incubated with
Hsp27 antibody (1:100, Santa Cruz, CA), goat polyclonal
anti-gdf 9 antibody (1:100, Santa Cruz, CA), rabbit poly-
clonal anti-cleaved-caspase 3 antibody (1:300; Cell Sig-
naling, Danvers, MA), rabbit polyclonal anti-cleaved-
caspase 8 antibody (1:200; Abcam, Cambridge, MA), rab-
bit monoclonal anti-caspase 9 antibody (1:200; Abcam)
and mouse monoclonal cyctochrome c antibody (1:100,
Santa Cruz) at 4°C overnight. After washing, oocytes
were incubated with a fluorescein isothiocyanate (FITC)-
conjugated secondary antibody (1:100; Beijing Zhong-
Shan Biotechnology Co., Beijing, China) for 1 h at 37°C,
and DNA was counterstained with PI (Sigma). Finally,
oocytes were mounted on glass slides with DABCO and
examined using ZEISS 510 laser confocal microscopy
(ZEISS Fluorescent Microsystems, Göttingen, Germany).
Western blot analysis
Oocytes of different treatment groups (1000 oocytes/
sample) were collected and added immediately into the
cell lysis composed of 7 M urea, 2 M thiourea, and 4%
CHAPS (W/V) and 1% DTT (W/V), 1% Cocktail (V/V).
Proteins were extracted and separated by SDS-PAGE, and
transferred onto a polyvinylidene difluoride (PVDF)
membrane (GE Healthcare, San Francisco, CA). Follow-
ing transfer, the membranes were blocked in Tris-buff-
ered saline (TBS) containing 5% skim milk for 1 h at room
temperature and then incubated overnight with primary
antibodies for cleaved-caspase 3 (1;500; Cell Signalling),
cleaved-caspase 8 (1:1000; Abcam), caspase 9 (1:1000,
Abcam), Hsp27(1:200; Santa Cruz), and β-tubulin
(1:1000; Abcam) at 4°C. After washing 3 times in TBST
for 10 min each time, the membrane was incubated for 1
h at 37°C with horseradish peroxidase (HRP)-conjugated
secondary antibody (Beijing ZhongShan, Beijing, China).
Figure 1 Ad-shHsp27 effects specific suppression of Hsp27 expression in mouse oocyte. (A) Immunofluorescence detection of Hsp27 expres-
sion after Ad-shHsp27 infection for 48 h. Oocytes were fixed in 4% paraformaldehyde and then stained with anti-Hsp27 antibody (green). Chromo-
some material was counterstained with propidium iodide (red). a) control-infected oocyte. b) shHsp27(1)-infected oocyte. c shHsp27(2)-infected 
oocyte. (B) The results of real time RT-PCR showing Ad-shHsp27 infection for 24 h in mouse oocytes. The expression level was calculated from the Ct 
values by the 2(-Delta Delta Ct) method, and the mRNA ratio (arbitrary units) of Hsp27 was calculated with respect to that of control. Bar graphs indi-
cate mean ± SD of four replicates. *P < 0.05 vs. control.Liu et al. Reproductive Biology and Endocrinology 2010, 8:47
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Figure 2 Localization and expression of Hsp27 in mouse oocytes from GV to MII cultured in vitro. (A) Immunofluorescence staining of Hsp27 
and chromosomes in maturing oocytes. Oocytes culturing for 0 h (GV), 3 h (GVBD), 8 h (MI) and 14 h (MII) in vitro were stained with specific Hsp27 
antibody (green) and propidium iodide (red). (B) Real time RT-PCR analysis of Hsp27 mRNA in maturing oocytes. Oocytes were cultured in vitro for 0, 
3, 8 and 14 h. A progressive increase was observed with the maturation of oocytes. (C) Western blot analysis of Hsp27 expression in maturing mouse 
oocytes. Experiments were repeated at least three times. Bars = 20 μm. *P < 0.05, **P < 0.01 vs. control.Liu et al. Reproductive Biology and Endocrinology 2010, 8:47
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The membrane was then washed 3 times in TBS-Tween
(TBST) for 10 min each, and processed using an
enhanced chemiluminescence detection system (Alpha
Innotech, San Leandro, CA). The molecular weights of
the detected proteins were deduced by comparison with
recombinant molecular weight standards (New England
BioLabs, Ipswich, MA).
Statistical analysis
Each experiment was repeated at least three times. All
data are presented as the mean ± SD, and one-way analy-
sis of variance and a log linear model were used to com-
pare the mRNA and protein levels. Chi-square analysis
was used to compare the rates of oocyte maturation and
early stage of apoptosis. A value of P < 0.05 was consid-
ered statistically significant, and if P < 0.01, it was noted.
Results
Construction of recombinant adenovirus Ad-shHsp27 and 
its expression
AD-293 cells were infected by the adenoviruses packaged
with hairpin siRNA targeted against Hsp27/control. The
results showed that the suppression rate of Hsp27 expres-
sion was as high as 75% vs. control (Data not shown, P <
0.05) after infecting with Ad-shHsp27 and control for 48
h.
To examine the reduction degree of Hsp27 mRNA in
mouse oocytes after infected with Ad-shHsp27 adenovi-
rus, real time RT-PCR was performed. As Figure 1B dis-
played, Ad-shHsp27 significantly reduced endogenous
Hsp27 mRNA abundance in mouse oocytes (50%). The
suppression degree of Hsp27 at protein level was detected
by immunofluorescence (Figure 1A), which was in accor-
dance with the real time PCR. These results suggested
that the knockdown of Hsp27 expression by Ad-shHsp27
infecting was effective. Therefore, these two siRNA were
chosen for the subsequent experiments.
Localization and expression of Hsp27 in the maturing 
oocytes
The localization of Hsp27 protein in maturing mouse
oocytes was showed in Figure 2A. Hsp27 expression was
recognized mainly in the cytoplasm and nuclei (except
the nucleolus) of mouse oocytes. To assess the levels of
Hsp27 mRNA in the maturing oocyte, real time RT-PCR
analysis was performed using cDNAs equivalent in
oocytes at different developmental stages (Figure. 2B).
Hsp27 expression dramatically increased following
oocyte maturation, Western blot analysis confirmed that
Hsp27 at protein level also increased following oocyte
maturation, and dramatically increased in MII (Figure.
2C), which was consistent with the results of real time
RT-PCR and immunofluorescence.
Microinjection of Hsp27 antibody into mouse oocytes
Polyclonal antibody of Hsp27 was microinjected into
oocytes cytoplasm at GV stage to downregulate the activ-
ity of Hsp27. After 3 h of microinjection, the GVBD rate
(77.0%) significantly increased, when compared with nor-
mal control (67.3%) or IgG-injected control (64.4%) (P <
0.01, vs IgG-injected group). After 14 h of microinjection,
the maturation rate of MII stage (67.3%) was also higher
than those of two controls (below 60%) (P < 0.01, vs IgG-
injected group; Table 2). These findings suggested that
the lowed Hsp27 activity in mouse oocytes could improve
the maturation of oocytes.
Table 3: Stages of oocyte nuclear maturation from the different treatment groups after 3 h and 14 h of IVM.
No. of oocytes (%)
Treatment Total Germinal vesicle breakdown Metaphase II
control 319 243(76.2) 194(60.8)
shHsp27(1) 336 298(88.7)** 257(76.4)**
shHsp27(2) 314 270(86.0)** 232(73.8)**
** Values are statistical significance at P < 0.01(vs. control).
Table 2: Maturation of mouse oocytes after microinjecting of Hsp27 antibody at 3 h and 14 h of in vitro culture.
No. of oocytes (%)
Treatment Total Germinal vesicle breakdown Metaphase II
Control 312 210(67.3) 186(59.6)
IgG 323 208(64.4) 178(55.1)
Antibody 365 281(77.0)** 246(67.3)**
** Values are statistical significance at P < 0.01(vs. IgG).Liu et al. Reproductive Biology and Endocrinology 2010, 8:47
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Infection of Ad-shHsp27 adenovirus into pellucida-free GV 
oocytes
Oocyte maturation of mouse zona-free GV oocytes was
significantly improved by infecting with Ad-shHsp27,
when compared with negative control at GVBD stage and
MII stage (Table 3). The maturation rates of GVBD stage
in shHsp27 (1), shHsp27 (2) groups were 86.0% and
88.7%, which were higher than control (76.2%) (P < 0.01).
Accordingly, compared with control (60.8%), the ratios of
MII stage in shHsp27 (1) and shHsp27 (2) groups (76.4%
and 73.8%) were also increased dramatically(P  < 0.01).
Same outcome was found in the antibody microinjection
(Table 2).
Annexin-V staining of oocytes
Oocytes were classified into three groups as Anguita et al
described [48]. The first group contained necrotic
oocytes with PI-positive red nuclei, indicative of mem-
brane damage. Oocytes with a discontinuous green signal
originating from the remnant portions of the membrane
were viable non-apoptotic oocytes (Figure. 3A). The sec-
ond group contained viable oocytes which were negative
for Annexin-V staining (Figure. 3B). The third group con-
sisted of early apoptotic oocytes with homogeneous
Annexin-V-positive signal in the membrane (Figure. 3C).
The ratios of Annexin-V-positive cells in two shHsp27
groups were higher than negative control (Table 4). After
3 h of treatment, the early apoptotic rate of oocytes
infected with Ad-shHsp27 (38.9%, 36.2%) was not signifi-
cantly different from control (33.8%). The ratios of early
apoptotic oocytes in shHsp27-treated groups after 8 h of
treatment were 46.5% and 45.6%, which were significantly
higher than the negative control (34.1%). The results sug-
gested that Hsp27 downregulation in oocytes could pro-
mote the early stage of apoptosis.
Variation of downstream apoptosis-related factors and 
oocyte secreted factors with defect of Hsp27 protein
To elucidate the involved apoptotic pathway(s), the
expressions of four apoptotic factors (caspases 8, caspase
9, caspase 3 and cytochrome c) were measured in oocytes
following different treatment by real time RT-PCR,
immunofluorescence and western blot. As shown in Fig-
ure 4 and Figure 5, the results of these assays were accor-
dant. Hsp27 downregulation in mouse oocytes
dramatically increased the activitied caspase 8 and cas-
Table 4: The rate of early stage of apoptosis in oocytes at 3 and 8 hours after siRNA adneovirus infection, was evaluated by 
Annexin-V staining in different groups (Control, shHsp27(1), shHsp27(2)).
3 h 8 h
Treatment Total No. of early apoptosis oocytes (%) Total No. of early apoptosis oocytes (%)
control 130 44 (33.8) 129 44 (34.1)
shHsp27(1) 131 51 (38.9) 131 61 (46.5)*
shHsp27(2) 149 54 (36.2) 125 57 (45.6)*
3 h and 8 h indicated the time of culture in vitro after adenovirus infection.
*Significant changes within group (* P < 0.05 vs. control).
Figure 3 Oocyte classification by Annexin-V staining. (A) necrotic oocytes. Discontinuous green signal was originated from the remnant portions 
of the membrane. (B) Oocyte Annexin-V negative: no signal in the cytoplasmic membrane. (C) Annexin-V positive (early stage of apoptosis): a clear 
green signal is observed in the oocyte membrane. Bars = 10 μm.Liu et al. Reproductive Biology and Endocrinology 2010, 8:47
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pase 3, while caspase 9 and cytochrome c activities did
not change. These results suggested that downregulation
of Hsp27 in mouse oocytes resulted in activation exclu-
sively of the extrinsic, caspase 8-mediated apoptotic
pathway, rather than the intrinsic, caspase 9-mediated
pathway.
In addition, the expressions of two important oocyte-
derived growth factors (bmp 15 and gdf 9) after downreg-
ulation of Hsp27 in mouse oocytes were also investigated
(Figure. 4A and 4B). The results indicated that bmp 15
and gdf 9 were increased significantly in oocyte after
downregulation of Hsp27.
Figure 4 Effect of Hsp27 downregulation in GV oocytes on the expression of some key apoptotic proteins and oocyte-derived growth fac-
tors. (A) Real time RT-PCR analysis in mouse oocytes after microinjecting Hsp27 antibody. Oocytes were cultured for 18-24 h. (B) Real time RT-PCR 
analysis in oocytes after infection with Ad-shHsp27. (C-F) Western blot analysis of key apoptotic factors in oocytes after infection with Ad-shHsp27. 
Measurements were plotted as the mean of at least three biological replicates ± SD. Changes are labeled as significant (*) if P < 0.05.Liu et al. Reproductive Biology and Endocrinology 2010, 8:47
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Page 9 of 12
Discussion
In the present study, the effect of Hsp27 downregulation
on oocyte development and maturation was investigated
in the mouse oocyte model cultured in vitro. Expression
of Hsp27 gene was downregulated in oocytes using
siRNA adenovirus infection, while the activity of Hsp27
was decreased by microinjection of polyclonal Hsp27
antibody into mouse GV oocytes. Interestingly, our
results showed that Hsp27 downregulation in mouse
oocytes improved oocyte maturation and increased
oocyte early stage of apoptosis.
Hsp27 was investigated as an antiapoptotic factor [49-
51]. Hsp27 could directly bind and co-precipitate with
cytochrome c, consequently leading to activation of the
caspase 9 and caspase 3 in mouse, rat and human cells
[31,33,52,53]. Kamradt et al reported that Hsp27 could
negatively regulate cytochrome c- and caspase 8-depen-
dent activation of caspase 3 in human breast carcinoma
cells [54]. To our knowledge, there were few reports
about the roles of Hsp27 in oocyte. In this pilot study,
after downregulation of Hsp27 in mouse oocytes, the
ratio of early stage of apoptosis was significantly
increased. Meanwhile, the expression of major apoptotic
factors i.e. caspase 3, caspase 8 was dramatically
increased. These results suggested that downregulation
of Hsp27 in mouse oocytes might increase early stage of
apoptosis by inducing the activation of the extrinsic, cas-
pase 8-mediated apoptotic pathway.
Our results showed that the lowed levels of Hsp27 sig-
nificantly increased GVBD rate and MII rates in both
siRNA infection group and antibody microinjection
group when compared with controls, indicating that
Hsp27 downregulation was positively related to oocyte
maturation. This result was also supported by detecting
the expression of two important oocyte-derived growth
factors-bmp 15 and gdf 9, which were known to be
responsible for controlling fundamental physiological
processes in oocyte development and follicular growth
[55]. Juengel et al reported that immunization against gdf
9 and bmp 15 alone or together in cattle oocytes could
block folliculogenesis and reduce follicular size, which
indicated the critical role of bmp 15 and gdf 9 on oocyte
development and follicular growth [56]. In this study, we
found that bmp15 and gdf 9 were noticeably upregulated
after Hsp27 downregulation in the mouse oocytes model
cultured in vitro, suggesting that there was an enhanced
effect of downregulated Hsp27 on oocyte development.
Recently, there were numerous studies focused on the
relation between early stage of apoptosis and oocyte
developmental competency in the pooled oocytes cul-
tured in vitro [12,48,57,58]. As we known, early stage of
apoptosis was regarded as a sequential, but reversible,
process of cell death [10,57]. As Anguita et al and Jaroudi
et al indicated, the oocytes undergoing early stage of
apoptosis did not mean that they must develop into late
apoptosis, early stage of apoptosis oppositely decreased
their developmental competence [48,59]. Bilodeau-Goe-
seels and Panich proved that oocytes with early signs of
atresia had good developmental potential by detecting
the transcriptional activity in early bovine embryos from
different classes of cumulus-oocyte complexes [60].
Additionally, some clinical studies provided consistent
results that oocytes from slightly atretic COCs with signs
of cumulus expansion had a better embryonic develop-
mental capacity after IVF than those considered to be of
the highest quality [61-65]. Concordantly, the percentage
of apoptotic cumulus cells increased when COCs were
exposed to FSH. Oocytes from those COCs exhibited a
higher developmental potential in terms of blastocyst for-
mation rate [66-68]. Those reports suggested that early
stage of apoptosis had a positive relation with the
improved oocyte developmental potential. In our present
study, downregulation of Hsp27 led to a lower antiapop-
totic effect and a significant increase in the GVBD rate
and MII rate, which was consistent with previous reports
[57]. Taking these results together, we speculated that
downregulation of Hsp27 induced early oocyte apoptosis,
consequently improving oocyte development. In fact, it is
difficult at present to understand the molecular mecha-
nism of the correlation between early stage of apoptosis
and subsequent maturation of oocyte in follicles in
PCOS. Our hypothesis is that downregulation of Hsp27
could be one of the bridges between those events, which
is our objectives in future studies.
Previous proteomic analysis comparing normal and
PCOS ovarian protein profiles identified that expression
of Hsp27 in PCOS ovaries was decreased when compared
with normal ovarian tissues [35]. PCOS is known as the
most common cause of anovulatory infertility, resulting
from a disorder of follicular maturation of uncertain aeti-
ology [15]. Several reports showed that apoptosis was
perturbed in PCOS ovaries, with overexpression of apop-
totic factors and downregulation of anti-apoptosis fac-
tors. However, the others showed the reversed results
[69-71]. Das et al reported that there were significant dif-
ferences in cell death rate and proliferation rate of granu-
losa cell populations in PCOS patients [72,73]. Oocyte
development is interdependent with its surrounding
granulose cells[11], and disfunction of granulose cells
may contribute to the abnormal folliculogenesis observed
in PCOS [5,74,75]. Interestingly, we found in this study
that the downregulated Hsp27 improved oocyte matura-
tion, which seems to be contradicted with the atresia fol-
licles observed in PCOS. One possible explanation for
this contradiction could be that our research was per-
formed in mouse oocyte model cultured in vitro. This
model simulates the normal oocyte's development, which
could be different from the pathological procedure ofLiu et al. Reproductive Biology and Endocrinology 2010, 8:47
http://www.rbej.com/content/8/1/47
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PCOS characterized by an abundance of large but imma-
t u r e  f o l l i c l e s .  W e  n e e d  m o r e  s t u d i e s  o n  t h e  e f f e c t s  o f
Hsp27 in PCOS pathophysiology in future studies.
Conclusions
In conclusion, evidence provided in the present study
indicated that downregulation of Hsp27 improved oocyte
maturation, and increased early apoptosis of mouse
oocytes by triggering the extrinsic, capsase 8-mediated
pathway. This is the first report, to our knowledge, to
establish a direct link between Hsp27 and oocyte matura-
t i o n .  R e l a t i v e  d e f i c i e n c y  o f  H s p 2 7  e x p r e s s i o n  i n  G V
oocytes may contribute to the disordered oocyte develop-
ment in PCOS. Further studies will be required to eluci-
date the role of Hsp27 in oocyte maturation in vivo and
PCOS pathophysiology.
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